Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$71,000 |
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$230,000 |
 |
ModernaMRNA |
$16,000 |
 |
AbbVieABBV |
$88,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros | Dec 19, 2025 | Buy | $1K - $15K |
| Julie Johnson | Dec 18, 2025 | Sell | $1K - $15K |
| Julie Johnson | Nov 13, 2025 | Sell | $1K - $15K |
| Val Hoyle | Sep 23, 2025 | Sell | $1K - $15K |
| Marjorie Taylor Greene | Aug 28, 2025 | Buy | $1K - $15K |
| Julie Johnson | Aug 14, 2025 | Sell | $1K - $15K |
| Gilbert Cisneros | Aug 5, 2025 | Buy | $1K - $15K |
| Lisa McClain | Aug 4, 2025 | Sell | $1K - $15K |
| Ritchie Torres | Jul 11, 2025 | Sell | $1K - $15K |
| Lisa McClain | Jun 24, 2025 | Buy | $1K - $15K |
| Scott Mr Franklin | Jun 16, 2025 | Sell | $1K - $15K |
| Julie Johnson | Jun 13, 2025 | Buy | $1K - $15K |
| Gilbert Cisneros | May 30, 2025 | Sell | $1K - $15K |
| Michael McCaul | May 19, 2025 | Buy | $50K - $100K |
| Rob Bresnahan | May 15, 2025 | Sell | $15K - $50K |
| Ro Khanna | May 9, 2025 | Sell | $1K - $15K |
| Marjorie Taylor Greene | May 5, 2025 | Buy | $1K - $15K |
| Gil Cisneros | Apr 29, 2025 | Buy | $1K - $15K |
| Bruce Westerman | Apr 21, 2025 | Sell | $1K - $15K |
| Jefferson Shreve | Apr 17, 2025 | Sell | $15K - $50K |
| Marjorie Taylor Greene | Apr 9, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | Apr 8, 2025 | Buy | $15K - $50K |
| Michael McCaul | Apr 2, 2025 | Buy | $100K - $250K |
| Gil Cisneros | Mar 31, 2025 | Sell | $15K - $50K |
| Sheri Biggs | Mar 19, 2025 | Sell | $15K - $50K |
| Bruce Westerman | Mar 3, 2025 | Buy | $1K - $15K |
| Gil Cisneros | Feb 26, 2025 | Buy | $15K - $50K |
| Rob Bresnahan | Feb 25, 2025 | Sell | $15K - $50K |
| Jefferson Shreve | Feb 24, 2025 | Buy | $15K - $50K |
| Josh Gottheimer | Jan 27, 2025 | Sell | $15K - $50K |
| Gil Cisneros | Jan 24, 2025 | Sell | $1K - $15K |
| Julie Johnson | Jan 17, 2025 | Buy | $1K - $15K |
| Byron Donalds | Jan 16, 2025 | Sell | $1K - $15K |
| Jared Moskowitz | Jan 15, 2025 | Sell | $1K - $15K |
| Keith Self | Jan 10, 2025 | Sell | $0 - $1K |
| Jared Moskowitz | Nov 8, 2024 | Buy | $1K - $15K |
| Ro Khanna | Oct 14, 2024 | Buy | $1K - $15K |
| Michael McCaul | Oct 9, 2024 | Sell | $1K - $15K |
| Ritchie Torres | Sep 26, 2024 | Buy | $1K - $15K |
| Jonathan Jackson | Sep 24, 2024 | Sell | $15K - $50K |
| Ro Khanna | Sep 9, 2024 | Buy | $1K - $15K |
| Scott Mr Franklin | Aug 7, 2024 | Buy | $1K - $15K |
| C. Scott Franklin | Aug 2, 2024 | Buy | $1K - $15K |
| Kathy Manning | Jul 2, 2024 | Buy | $1K - $15K |
| Josh Gottheimer | Jun 21, 2024 | Sell | $1K - $15K |
| Michael Burgess Republican | Apr 10, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Feb 23, 2024 | Buy | $15K - $50K |
| Michael McCaul Republican | Feb 20, 2024 | Sell | $1K - $15K |
| Michael McCaul Republican | Feb 20, 2024 | Sell | $1K - $15K |
FAQ - Congress Trading
Gilbert Cisneros purchased Merck & Company shares most recently on December 19, 2025.
Michael McCaul has bought the most MRK stock in the last 2 years, with an estimated value of $250,000.
Rob Bresnahan has sold the most MRK stock in the last 2 years, with an estimated value of $66,000.
According to our estimates, the net value of trades by US politicians for Merck & Company in the last 2 years is positive, amounting to $140,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Merck & Company have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
